| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3748 |
| Trial ID | NCT06247501 |
| Disease | Very High Risk Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SNUH-CD19-CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation |
| Year | 2024 |
| Country | Korea, Republic of |
| Company sponsor | Seoul National University Hospital |
| Other ID(s) | SNUH-CART-CD19-SCT |
| Cohort 1 | |||||||||
|
|||||||||